Substance | Condition | Seq | Src | PMID | Dtl | Title |
Procyanidins | Diabetes | 1 | PM | 32659127 | 📋 | Screening active components from Rubus amabilis for pancreatic β-cells protection |
Procyanidins | Diabetes | 2 | PM | 17098323 | 📋 | Oligomeric Procyanidins of French Maritime Pine Bark Extract (Pycnogenol) Effectively Inhibit Alpha-Glucosidase |
Procyanidins | Diabetes Type 2 | 1 | PM | 28303711 | 📋 | Phenolic Elderberry Extracts, Anthocyanins, Procyanidins, and Metabolites Influence Glucose and Fatty Acid Uptake in Human Skeletal Muscle Cells |
Procyanidins | Diabetes Type 2 | 2 | PM | 27792335 | 📋 | Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice |
Procyanidins | Diabetic Complications | 2 | PM | 32815169 | 📋 | Proteomic analysis of liver mitochondria of db/db mice treated with grape seed procyanidin B2 |
Procyanidins | Diabetic Retinopathy | 1 | PM | 34636125 | 📋 | Procyanidin protects human retinal pigment epithelial cells from high glucose by inhibiting autophagy |
Procyanidins | Gestational Diabetes | 1 | PM | 35567986 | 📋 | Procyanidins and its metabolites by gut microbiome improves insulin resistance in gestational diabetes mellitus mice model via regulating NF-κB and NLRP3 inflammasome pathway |
Procyanidins | Hyperglycemia | 2 | PM | 37803795 | 📋 | Peanut skin procyanidins reduce intestinal glucose transport protein expression, regulate serum metabolites and ameliorate hyperglycemia in diabetic mice |
Procyanidins | Hyperglycemia | 1 | PM | 32326848 | 📋 | Inhibitory effects of bioaccessible anthocyanins and procyanidins from apple, red grape, cinnamon on α-amylase, α-glucosidase and lipase |
Procyanidins | Postprandial Hyperglycemia | 1 | PM | 32801470 | 📋 | The cacao procyanidin extract-caused anti-hyperglycemic effect was changed by the administration timings |
Procyanidins | Prediabetes | 1 | PM | 28505543 | 📋 | Chronic administration of apple polyphenols ameliorates hyperglycaemia in high-normal and borderline subjects: A randomised, placebo-controlled trial |